𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retention of the CDKN2A locus and low frequency of point mutations in primary and metastasic cutaneous malignant melanoma

✍ Scribed by Anna Ruiz; Susana Puig; Michael Lynch; Teresa Castel; Xavier Estivill


Publisher
John Wiley and Sons
Year
1998
Tongue
French
Weight
124 KB
Volume
76
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


CDKN2A has been found mutated in melanoma families which show linkage to chromosome 9p21. In contrast, a low mutation rate has been found in melanomas, suggesting that CDKN2A might not be the first target for mutation in the development of this type of tumour. To elucidate the role of the CDKN2A gene and its alternative transcript p19ARF in the development of cutaneous malignant melanoma (CMM) we have analyzed 48 primary and metastasic CMM tumours for mutations and for loss of heterozygosity (LOH). Only one point mutation was detected (2%), while hemizygous deletions were identified in 20% of these tumours. Retention of the CDKN2A locus was found in 10 (47%) tumours with deletions at one or both sides of CDKN2A, suggesting that loss of this gene is not involved in CMM-tumour initiation and that another tumour-suppressor gene involved in melanoma is located at 9p21. Int.


πŸ“œ SIMILAR VOLUMES


The risk of subsequent primary carcinoma
✍ Maryjean Schenk; Richard K. Severson; Karen S. Pawlish πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

## Background: Carcinoma of the pancreas is the fifth leading cancer in the u.s. and has the poorest survival rate of the major malignancies. recent studies have reported an increased risk of carcinoma of the pancreas in malignant melanoma-prone kindreds and have suggested a link between malignant

Complete scanning of the CDK4 gene by de
✍ Per Guldberg; Alexei F. Kirkin; Kirsten GrΓΈnbΓ¦k; Per thor Straten; Vibeke Ahrenk πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 60 KB πŸ‘ 1 views

The cyclin-dependent kinase 4 (CDK4) is a key component in regulation of the mammalian cell cycle. The recent discovery of a common missense mutation (Arg24Cys) in both sporadic and familial forms of malignant melanoma strongly supports the candidacy of CDK4 as a proto-oncogene. To study further the